Introduction {#s1}
============

African Animal Trypanosomiasis is one of the major constraints on the productivity of pastoralists in sub-Saharan Africa and can be caused by infection by a range of trypanosome species ([@bib42]), while infections of humans are caused by only two subspecies of *Trypanosoma brucei* ([@bib24]; [@bib32]). The disease is persistent as the host immune system is usually unable to clear the infection. This is due to the trypanosome having evolved a population survival strategy based on autoregulation of parasitaemia and antigenic variation ([@bib26]; [@bib18]). The trypanosomes also internalize and degrade surface bound immunoglobulin ([@bib31]; [@bib10]), increasing the survival of an individual cell and thereby increasing the likelihood of transmission. Both of these strategies require a densely packed cell surface coat of variant surface glycoprotein (VSG) that acts as a barrier, preventing access of host immunoglobulins to the plasma membrane ([@bib40]). This coat also undergoes antigenic variation through expression of a single VSG gene from a genomic repertoire of hundreds ([@bib18]).

Although the VSG coat restricts immunoglobulin access, it must be permissive for receptor-mediated binding and uptake of macromolecular ligands. *T. brucei*, and the closely related *T. congolense*, have receptors for both transferrin (TfR) for iron ([@bib43]; [@bib39]; [@bib19]) and haptoglobin-haemoglobin (HpHbR) for haem ([@bib47]; [@bib16]). These are held on the external face of the plasma membrane by covalent attachment of the C-terminal carboxyl group to a glycosylphosphatidyl inositol to form a GPI-anchor. All have free movement in the lateral plane of the membrane, although the receptors are concentrated in the flagellar pocket, an invagination of the plasma membrane at the base of the flagellum and the site of all endocytosis ([@bib30]; [@bib47]).

Humans, together with a few other primates, display innate immunity to most trypanosome species ([@bib24]) through the action of trypanolytic factors-1 and -2 (TLF1 and TLF2) ([@bib15]; [@bib37], [@bib38]). Although containing different scaffold components, these factors both include apolipoprotein L1 (ApoL1) together with complexes of haemoglobin bound to haptoglobin-related protein (HprHb) ([@bib46]; [@bib34]). TLF1 enters trypanosomes via receptor-mediated endocytosis, through binding of the HprHb component to HpHbR ([@bib8]; [@bib48]; [@bib47]). This delivers ApoL1 to the endosome where it causes lysosomal swelling and cell death ([@bib34]). In contrast, the uptake route for TLF2 is unclear as, unlike TLF1, it is able to kill HpHbR null mutants ([@bib6]; [@bib45]).

Just two subspecies of *T. brucei* (*T. b. rhodesiense* and *T. b. gambiense*) have evolved counter measures to the trypanolytic factors, allowing them to cause Human African Trypanosomiasis ([@bib33]). In the case of human-infective group 1 *T. b. gambiense*, a unique point polymorphism is found in HpHbR ([@bib44]) that reduces the monovalent affinity for ligand by 20-fold ([@bib16]). This contributes to resistance to TLF1, illustrating the importance of HpHbR.

Haptoglobin-haemoglobin is an elongated 'dumbell-shaped' complex consisting of a dimer of haptoglobin molecules, each joined to an αβ haemoglobin dimer ([@bib1]). Trypanosomes take up this HpHb complex but not the individual components ([@bib47]). The structure of the *T. congolense* HpHbR is an elongated three-helical bundle with a small membrane distal head ([@bib16]). Residues involved in HpHb binding are part of a small conserved patch ∼25 Å below the tip of the receptor, but details of ligand binding and uptake were not characterized.

Here, we present the structure of *T. brucei* HpHbR. We show that the receptor adopts a similar architecture to its *T. congolense* homologue, but with a ∼50° kink a third of the way along from the membrane proximal end. We also present the structure of TbHpHbR in complex with HpHb, revealing the molecular basis for ligand binding and selectivity. Finally, we show that the kink allows two independent membrane attached receptors to interact with a single dimeric HpHb molecule and confirm using cell uptake experiments that this causes dimeric ligand to be taken up with greater efficiency than monomeric ligand. This reveals the molecular basis for the uptake of HpHb and trypanolytic factor-1 and identifies adaptations in the trypanosome receptor that allow efficient ligand uptake in the context of the tightly packed VSG coat.

Results {#s2}
=======

TbHpHbR binds to the HpSP domain:Hb head structure {#s2-1}
--------------------------------------------------

To provide detailed molecular knowledge of the mechanism of uptake of haptoglobin-haemoglobin and trypanolytic factor-1 (TLF1), we aimed to determine the structure of *T. brucei* HpHbR (TbHpHbR) alone and bound to a human haptoglobin-haemoglobin complex.

TbHpHbR is longer than its homologue from *T. congolense* due to the presence of an additional C-terminal membrane-proximal domain. We therefore used the previously determined structure of *T. congolense* HpHbR ([@bib16]) to design a construct containing the corresponding region of TbHpHbR (residues 36--299). This region of the protein is identical in the human infective *T. b. rhodesiense*.

Haptoglobin-haemoglobin consists of a dimer of haptoglobin chains, each interacting with an αβ dimer of haemoglobin, and adopts a dimeric 'dumbell-shaped' architecture ([@bib1]). At each end, a serine protease (HpSP) domain of haptoglobin forms a stable complex with a haemoglobin dimer. Dimerisation occurs through an interface formed by the CCP domains of haptoglobin, linking together these HpSPHb 'heads'.

Previous studies have shown that TbHpHbR interacts with the HpHb complex but not with either haptoglobin or haemoglobin alone ([@bib47]), suggesting that that the receptor most likely binds to the heads of HpHb, where its two constituent components come together. We therefore designed a human haptoglobin construct containing just the SP domain (residues 148--406). This was expressed in baculovirus-infected insect cells and was combined with haemoglobin extracted from human blood to assemble HpSPHb complexes. We used surface plasmon resonance to determine the affinity of these HpSPHb complexes for TbHpHbR, and showed binding with an affinity of 0.7 μM ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), similar to the 1 μM affinity observed for intact human HpHb ([@bib16]).

Proteolytic cleavage of haptoglobin normally occurs in the endoplasmic reticulum after residue R102 but this cleavage event did not occur in the insect cell expressed HpSP domain. However, this did not affect the affinity for TbHpHbR. The shortened TbHpHbR construct and the HpSPHb complex therefore interact together with the same affinity as the full-length components, providing reagents for structural determination. These findings also confirm that TbHpHbR binds to the 'head' structure of dimeric HpHb, raising the possibility of two receptors simultaneously interacting with one HpHb complex.

Determination of the structure of TbHpHbR alone and in complex with HpSPHb {#s2-2}
--------------------------------------------------------------------------

To investigate the molecular basis for HpHb binding by TbHpHbR, crystallisation plates were set up for HpSPHb, TbHpHbR and a complex containing TbHpHbR bound to HpSPHb. Crystals of HpSPHb diffracted to 2.05 Å and were of space group P3~1~21 with one complex in the asymmetric unit. Crystals of TbHpHbR diffracted to 1.85 Å resolution and were of space group P2~1~ with two molecules in the asymmetric unit. Crystals of the TbHpHbR:HpSPHb complex were of space group C2 and diffracted to 3.1 Å resolution with a single complex in the asymmetric unit ([Table 1](#tbl1){ref-type="table"}).10.7554/eLife.05553.003Table 1.Crystallographic data collection statistics**DOI:** [http://dx.doi.org/10.7554/eLife.05553.003](10.7554/eLife.05553.003)HpSPHbTbb HpHbRTbbHpHbR:HpSPHbBeamlineDiamond I04-1Diamond I03Diamond I03Space Groupp3~1~21p2~1~c2Cell dimensions (Å)a = b = 96.6, c = 132.77a = 27.90, b = 47.79, c = 203.38, β = 92.79a = 223.4, b = 56.59, c = 65.29, β = 92.99Resolution (Å)2.051.853.1Wavelength (Å)0.9160.97630.9750R~PIM~ (%)8.1 (37.4)4.5 (42.9)6.3 (72.6)I/ σ(I)8.7 (2.3)10.2 (2.0)9.8 (1.6)Completeness (%)99.8 (100)97.4 (96.5)96.9 (97.1)Multiplicity9.6 (10.2)3.1 (3.1)3.2 (3.3)

The structure of human HpSPHb was determined using molecular replacement with the equivalent region of porcine HpHb (pdb: 4F4O) as a search model. The structure of the TbHpHbR:HpSPHb complex was then determined through molecular replacement using HpSPHb as a search model, allowing a poly-alanine model of TbHpHbR to be built. This model was then used as a molecular replacement search model to determine the structure of TbHpHbR using higher-resolution data obtained from crystals of the receptor alone. Both structures were then completed using iterative cycles of model building and refinement ([Table 2](#tbl2){ref-type="table"}).10.7554/eLife.05553.004Table 2.X-ray refinement statistics**DOI:** [http://dx.doi.org/10.7554/eLife.05553.004](10.7554/eLife.05553.004)ComplexHpSPHbTbb HpHbRTbbHpHbR:HpSPHbResolution (Å)2.051.853.1No. reflections43,17044,68517,302R~work~ / R~free~ (%)18.0 / 22.419.84 / 23.9519.5 / 21.7No. of protein residues in model544523782rmsd bond lengths (Å)0.0200.0170.012rmsd bond angles (°)2.01.61.5Ramachandran plotAllowed region89.0%98.8%92.5%Additional allowed region11%1.2%7.5%Generously allowed region0%0%0%Disallowed region0%0%0%

The structure of the *T. brucei* haptoglobin-haemoglobin receptor {#s2-3}
-----------------------------------------------------------------

Like *T. congolense* HpHbR, the *T. brucei* receptor is elongated, consisting primarily of a three-helical bundle ([Figure 1](#fig1){ref-type="fig"}): helix I (red; residues 42--110), helix II (orange; residues 116--182), and helix V (dark blue; residues 224--296) with a total length of 118 Å. At the membrane distal end, the receptor widens to form a compact head structure that includes the N-terminus and a 42-residue loop containing two further helices, helix III (yellow: residues 186--196) and helix IV (green: residues 207---218). The upper part of the structure is extremely similar to that from *T. congolense*, with the membrane distal halves of the two receptors aligning with a root mean square deviation of 1.1 Å ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).10.7554/eLife.05553.005Figure 1.The structure of the *T. brucei* haptoglobin-haemoglobin receptor.(**A**) The structure of the *T. brucei* haptoglobin-haemoglobin receptor, with helix I (red), helix II (orange) and helix V (blue). These three helices form an elongated bundle with a ∼50° kink towards the membrane proximal C-terminal end. The inset shows a molecular envelope derived from small angle x-ray scattering. (**B**) The structure of the *T. congolense* haptoglobin-haemoglobin receptor ([@bib16]) for comparison. (**C**) A change in the pattern of hydrophobic residues results in a rigid kink in the three helical bundle of the TbHpHbR. Corresponding regions of the structures of TbHpHbR and TcHpHbR are shown with side chains of the hydrophobic residues that pack in the core of the bundle coloured red and residues at the kink sites in TbHpHbR coloured green. Also shown are sequence alignments of TbHpHbR and TcHpHbR for these regions of each helix, coloured in the same way.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.005](10.7554/eLife.05553.005)10.7554/eLife.05553.006Figure 1---figure supplement 1.Surface plasmon resonance analysis of the binding of HpSPHb to TbHpHbR.Surface plasmon resonance signals for twofold dilutions of HpSPHb complex from a maximum concentration of 16 μM, binding to a surface coated with the truncated version of *T. brucei* HpHbR.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.006](10.7554/eLife.05553.006)10.7554/eLife.05553.007Figure 1---figure supplement 2.Alignment of the TbHpHbR and TcHpHbR structures.Structural alignment of *T. brucei* HpHbR (blue) with *T. congolense* HpHbR (red). The membrane distal (upper) halves of the receptors align with a root mean square deviation of 1.1 Å while the membrane proximal (lower) halves differ due to the presence of a ∼50° kink in TbHpHbR.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.007](10.7554/eLife.05553.007)

The most dramatic difference between the *T. brucei* and *T. congolense* receptors is a ∼50° kink in TbHpHbR, located approximately one-third of the way along the receptor from the membrane proximal end. Each of the three helices is affected, with the backbone carbonyl groups of Asp88, Ala89, Glu123, Asn124, Asp270 and Ala271 no longer forming hydrogen bonds. This kink is not caused by flexibility, but is a rigid feature of the receptor, as it adopts the same confirmation in crystals of receptor alone, and in crystals of its complex with HpSPHb ([Figure 2A](#fig2){ref-type="fig"}), and is also observed in molecular envelopes derived from small angle x-ray scattering ([Figure 1](#fig1){ref-type="fig"}, [Table 3](#tbl3){ref-type="table"}). Instead it is caused by changes in the pattern of hydrophobic and hydrophilic residues around the kink site in each of the three helices. The three long helices of the *T. congolense* receptor are characterised by an alternating pattern of hydrophobic and hydrophilic residues, leading to continuous hydrophobic strips along the length of each helix that pack in the core of the helical bundle, stabilising its fold. In the *T. brucei* receptor, this pattern is disturbed at each kink site, breaking the organisation of the helix and leading to an alteration in the surface that displays the hydrophobic patch ([Figure 1C](#fig1){ref-type="fig"}). This stabilises the kink and makes it a rigid feature of the receptor structure.10.7554/eLife.05553.008Figure 2.The structural basis for haptoglobin-haemoglobin binding by TbHpHbR.(**A**) The structure of the complex between *T. brucei* HpHbR (blue) bound to its ligand, HpSPHb (haptoglobin is yellow, the β-subunit of haemoglobin is red and the α-subunit of haemoglobin is orange). (**B**) The complex viewed from the membrane proximal end, showing the contacts made by haptoglobin and the β-subunit of haemoglobin. (**C**) A view of the haemoglobin-binding site showing direct contacts between the haem and the receptor. Residues from the receptor that directly contact the haemoglobin subunit are shown as sticks and are numbered.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.008](10.7554/eLife.05553.008)10.7554/eLife.05553.009Figure 2---figure supplement 1.Stereoview of the TbHpHbR in complex with HpHb.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.009](10.7554/eLife.05553.009)10.7554/eLife.05553.010Figure 2---figure supplement 2.Small angle x-ray scattering of complexes of TcHpHbR and TbHpHbR with HpSPHb.(**A**) The structure of the TbHpHbR:HpSPHb complex docked into an ab initio molecular envelopes calculated from scattering data. (**B**) The theoretical scattering calculated from ab initio reconstructions (blue for HpSPHb, red for TbHpHbR and purple for TbHpHbR:HpSPHb), superimposed into experimental scattering data. Guinier plots are shown as an insert. (**C**) Distance distribution functions of HpSPHb (blue), TbHpHbR (red) and TbHpHbR:HpSPHb (purple) derived from small angle x-ray scattering. (**D**) A model of the TcHpHbR:HpSPHb complex docked into an ab initio molecular envelope calculated from scattering data. (**E**) The theoretical scattering calculated from an ab initio reconstruction of the TcHpHbR:HpSPHb complex. (**F**) Distance distribution function of TcHpHbR:HpSPHb derived from small angle x-ray scattering.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.010](10.7554/eLife.05553.010)10.7554/eLife.05553.011Figure 2---figure supplement 3.Clashes between TbHpHbR and a haemoglobin tetramer explain why the receptor does not bind to haemoglobin.A model for a complex of TbHpHbR bound to haemoglobin. This was derived by docking a haemoglobin tetramer onto the receptor with the β-subunit binding to the receptor as in the TbHpHbR:HpSPHb complex. TbHpHbR is shown in blue, the α-subunits of haemoglobin are orange and the β-subunits are red. A close up of the model is shown in the right hand panel with side chains involved in clashes shown as sticks.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.011](10.7554/eLife.05553.011)10.7554/eLife.05553.012Figure 2---figure supplement 4.The region affected by haptoglobin cleavage is not involved in interaction with TbHpHbR.(**A**) The structures of the HpSPHb region of porcine HpHb (red) aligned to the equivalent region of human HpSPHb from the structure of the TbHpHbR:HpSPHb complex (yellow). The structures align with a root mean square deviation of ∼0.5 Å. The major difference is circled and lies around the site at which haptoglobin is cleaved during a processing event in the endoplasmic reticulum, which is disordered in the TbHpHbR:HpSPHb complex. (**B**) A structural alignment of the porcine HpSPHb structure onto the TbHpHbR:HpSPHb structure. The region that is structurally altered by cleavage is circled and is not involved in contacts with the receptor. This is confirmed by surface plasmon resonance data ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) which shows that TbHpHbR binds with similar affinity to HpSPHb as to previously measured native, cleaved HpHb.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.012](10.7554/eLife.05553.012)10.7554/eLife.05553.013Table 3.Small angle x-ray scattering statistics**DOI:** [http://dx.doi.org/10.7554/eLife.05553.013](10.7554/eLife.05553.013)MW (kDa)R~G~ (nm)D~max~ (nm)Volume (nm^3^)Mw~app~ (kDa)HpSPHb59.72.67.57536TbHpHbR32.23.511.54422TbHbHbR:HpSPHb91.83.210.811055TbHpHbR:HpSPHb89.63.812.014070HpHb1525.618.2214107TbHpHbR:HpHb2176.316.5370185

The structure of TbHpHbR in complex with haptoglobin-haemoglobin {#s2-4}
----------------------------------------------------------------

The structure of the TbHpHbR:HpSPHb complex reveals an unexpected binding mode in which the ligand-binding surface extends along more than half of the length of the receptor ([Figure 2](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Residues previously identified as playing a role in HpHb binding in TcHpHbR, such as S59 ([@bib16]), lie ∼35 Å from the membrane distal tip of the receptor and directly contact haemoglobin. However, this is the upper part of the binding site, with residues from haptoglobin interacting as far as 70 Å from the membrane distal tip. This arrangement is confirmed by small angle x-ray scattering, with complexes of HpSPHb bound to either *T. brucei* or *T. congolense* receptors showing a similar architecture to that observed in the crystal ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, [Table 3](#tbl3){ref-type="table"}).

The haptoglobin-haemoglobin complex covers a total area of ∼1250 Å^2^ of the receptor and can be divided into two distinct regions ([Figure 2B](#fig2){ref-type="fig"}). The membrane distal part, (∼745 Å^2^) contacts the β-subunit of the haemoglobin dimer with no contacts between the receptor and the haemoglobin α-subunit. The membrane proximal region (∼505 Å^2^) forms a binding surface for haptoglobin. The involvement of both haemoglobin and haptoglobin in binding explains why the receptor binds HpHb but not haptoglobin alone. Modelling suggests that the lack of haemoglobin binding is due to steric clashes of the receptor with the second αβ dimer of haemoglobin when the β-subunit of a haemoglobin tetramer is docked onto the receptor with the binding mode observed in the TbHpHbR:HpSPHb complex ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Therefore, the conformation of the receptor and the presence of two distinct binding sites allow the receptor to specifically select HpHb over its two constitutive components.

The haemoglobin β-subunit makes a number of direct interactions, mostly hydrogen bonds, with the receptor ([Figure 2C](#fig2){ref-type="fig"}, [Table 4](#tbl4){ref-type="table"}). Side chains from helix I of the receptor make the majority of these contacts, with additional interactions from helix II and the loop that links helices III and IV. These features lie along a groove on haemoglobin that is formed by helices C and F of the β-subunit. The haem group also makes direct contacts with the receptor, with the propionate chains contacting residues K56, S59, K164, R199 and Y200 of the receptor. These interactions, mediated by haem, form ∼140 Å^2^ of the ∼745 Å^2^ total contact area of Hb.10.7554/eLife.05553.014Table 4.Interactions between TbHpHbR and HpSPHb**DOI:** [http://dx.doi.org/10.7554/eLife.05553.014](10.7554/eLife.05553.014)ReceptorHpSPHbResidueGroupChainResidueGroupInteractionHbβK56side chainBHaem144O1DHydrogen bondE57side chainBK96Side chainSalt bridgeS59side chainBHaem144O1D/O2DHydrogen bondI60side chainBPatchHydrophobicR67side chain NH1BR41Backbone COHydrogen bondE70side chain OE1/OE2BR41Side chain NE/NH2Salt bridgeS161side chainBK60Side chainHydrogen bondS161side chainBS45Backbone COHydrogen bondK164side chainBHaem144O2DHydrogen bondR199side chain NEBHaem144O2AHydrogen bondY200side chain OHBHaem144O2AHydrogen bondS203backbone COBK96Side chainHydrogen bondHpSPS73side chainCK345Side chainHydrogen bondV74hydrophobicCPatchHydrophobicQ75OE1CG276Backbone COHydrogen bondA78side chainCPatchHydrophobicA82side chainCPatchHydrophobicK85side chainCD305Side chain O2DSalt bridge

The haptoglobin subunit also interacts with helix I of the receptor, through a predominantly hydrophobic contact, mediated by three loops that emerge from the C-terminal β-sheet of haptoglobin ([Figure 2B](#fig2){ref-type="fig"}, [Table 4](#tbl4){ref-type="table"}). The structure of human haptoglobin from this complex aligns with that from porcine Hp with a root mean square deviation of just 0.5 Å and reveals no significant structural change on receptor binding ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). The alignment also confirms that the natural cleavage of Hp does not affect TbHpHbR binding, as residues in the loop that contains the cleavage site are not close to the receptor.

Rather than haptoglobin, trypanolytic factor-1 (TLF1) contains haptoglobin-related protein (Hpr) and binding of HprHb complex to TbHpHbR results in TLF1 uptake. The HprSP domain contains a total of sixteen amino acid substitutions when compared with the HpSP domain. Mapping these onto the structure shows that none of these differences lie in residues that contact the receptor ([Figure 3A](#fig3){ref-type="fig"}). Indeed HprSPHb complexes, prepared using the same protocols as HpSPHb complexes, bound to the receptor with an affinity of 1.7 μM, as determined by surface plasmon resonance ([Figure 3B](#fig3){ref-type="fig"}), comparable to the 0.7 μM affinity of the receptor for HpSPHb. This suggests that HprHb, and as a result, TLF1, will have a shared binding mode with HpHb.10.7554/eLife.05553.015Figure 3.Differences between haptoglobin and haptoglobin-related protein do not alter affinity for TbHpHbR.(**A**) The structure of the TbHpHbR:HpSPHb complex is shown with the receptor in blue and haptoglobin in yellow. Side chains in haptoglobin that are different in haptoglobin-related protein are highlighted in pink and are not involved in making interactions with the receptor. (**B**) Surface plasmon resonance signals for two-fold dilutions of HprSPHb complex from a maximum concentration of 8 μM, binding to a surface coated with *T. brucei* HpHbR. The measured affinity of 1.7 μM can be compared with the affinity of 0.7 μM for HpSPHb.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.015](10.7554/eLife.05553.015)

A model for haptoglobin-haemoglobin uptake in the context of the VSG layer {#s2-5}
--------------------------------------------------------------------------

The haptoglobin-haemoglobin receptor operates in the context of the VSG layer, a dense coat of surface protein that covers the trypansosome surface. It is therefore initially surprising that the location of the binding site for bulky HpHb complexes extends some 70 Å from the membrane distal tip of the receptor and below the surface of the VSG layer. However, one consequence of the kink in the *T. brucei* receptor is to increase its effective diameter, pushing apart VSG molecules. In addition, the orientation of the kink is precisely arranged to increase exposure of the HpHb binding site to the surface, making it more accessible for ligand binding.

Docking of TbHpHbR:HpSPHb structures onto the structure of dimeric porcine HpHb reveals another consequence of the kink. This modelling suggests that two receptors can bind simultaneously to a single HpHb dimer, resulting in a C-shaped complex with a parallel arrangement of the membrane proximal parts of the two receptors ([Figure 4A](#fig4){ref-type="fig"}). Indeed, this arrangement was confirmed in solution by small angle x-ray scattering. Native (dimeric) human HpHb was mixed with TbHpHbR, and gel filtration was performed, with SAXS data collected from samples as they emerged from the column. The resultant scattering curves confirmed the assembly of a complex containing two receptors and one HpHb in vitro. These data were used to generate a molecular envelope for the complex, which confirmed the C-shaped architecture ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, [Table 3](#tbl3){ref-type="table"}). Additional support for the formation of this complex in solution came from multi-angle laser light scattering (SEC-MALLS), which revealed masses of 30 kDa for the receptor, 150 kDa for HpHb and 210 kDa for the complex, showing that two receptors bind to each HpHb in solution ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). This arrangement, in which two independent GPI-anchored receptors can bind simultaneously to an HpHb dimer, would increase avidity for the ligand and decrease the ligand concentration required for efficient uptake.10.7554/eLife.05553.016Figure 4.Simultaneous binding of two receptors to each HpHb dimer leads to more efficient uptake into trypanosomes.(**A**) A model for a complex of one HpHb dimer bound to two receptors, generated by docking the structure of the TbHpHbR:HpSPHb complex onto that of porcine HpHb ([@bib1]). The receptors are organized such that two receptors, both associated with the membrane through attachment at their C-termini, can simultaneously bind to one HpHb dimer. (**B**) An ab initio molecular envelope derived from small angle x-ray scattering analysis of the TbHpHbR:HpHb complex supports the formation of a complex containing one HpHb dimer bound to two receptors. (**C**) Uptake of fluorescently labelled dimeric HpHb into live cells was monitored via flow cytometry across a range of 1--62.5 nM. Uptake saturated by 4 nM in wild-type cells whereas no uptake was observed in the HpHbR null cell line. No fluid phase uptake of labelled BSA was observed at these concentrations. (**D**) Uptake of fluorescently labelled monomeric HpSPHb was not readily detected until 62.5 nM, at which point uptake had not saturated. HpSPHb uptake at 62.5 nM was lost in the HpHbR null cell line. Each uptake assay was carried out in triplicate. Error bars represent standard error of the mean, n = 3.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.016](10.7554/eLife.05553.016)10.7554/eLife.05553.017Figure 4---figure supplement 1.Small angle x-ray scattering of HpHb, alone and in complex with TbHpHbR.(**A**) An ab initio molecular envelopes calculated from scattering data from the HpHb complex. (**B**) The theoretical scattering calculated from ab initio reconstructions for HpHb superimposed into experimental scattering data. Guinier plots are shown as an insert. (**C**) Distance distribution functions of HpHb derived from small angle x-ray scattering. (**D**) An ab initio molecular envelopes calculated from scattering data from the TbHpHbR:HpHb complex. (**E**) The theoretical scattering calculated from ab initio reconstructions for TbHpHbR:HpHb superimposed into experimental scattering data. Guinier plots are shown as an insert. (**F**) Distance distribution functions of TbHpHbR:HpHb derived from small angle x-ray scattering.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.017](10.7554/eLife.05553.017)10.7554/eLife.05553.018Figure 4---figure supplement 2.SEC MALLS data to assess the stoichiometry of the TbHpHbR:HpHb complex.Multi-angle light scattering (MALLS) measurements of TbHpHbR (red), HpHb (blue) and the TbHpHbR:HpHb complex (green). The molecular weights determined from scattering data (∼30 kDa for TbHpHbR, ∼150 kDa for HpHb and ∼210 kDa for the TbHpHbR:HpHb complex) show the formation of a complex containing two receptors bound to a single HpHb.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.018](10.7554/eLife.05553.018)10.7554/eLife.05553.019Figure 4---figure supplement 3.Establishment and characterization of an HpHb^−/−^ cell line of *T. brucei*.TbHpHbR null cell lines were generated in *T. b. brucei* Lister 427 bloodstream form (BSF) cells. (**A**) The TbHbHbR gene was knocked out in Lister 427 BSF cells by replacement of one allele with a blasticidin resistance gene and the other allele with a neomycin resistance gene in four independent clones, as confirmed by Southern blot (P = Parental cell line, 1--4 = TbHpHbR null clones 1--4). The schematic depicts the original (top) and replacement (middle and lower) TbHpHbR loci and the positions of Southern blot probes and restriction enzyme sites used. Expected fragment sizes are annotated. (**B**) Growth of the TbHpHbR null clones was monitored in vitro over 192 hr. Parental L427 cells grew with a mean doubling time of 8.4 hr whereas the TbHpHbR null clones had an increased mean doubling time of 11.5--12.0 hr. Error bars represent standard deviation, n = 8.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.019](10.7554/eLife.05553.019)

To test this hypothesis, we performed uptake experiments using *T. brucei*. HpHb (dimeric), HpSPHb (monomeric) and bovine serum albumin (BSA, as a control to assess fluid phase uptake), were each fluorescently labelled. In addition, we prepared a null cell line, TbHpHbR^−/−^, in which both copies of the receptor were disrupted ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). These reagents allowed us to investigate the concentration dependence of ligand uptake. In wild-type *T. brucei* cells, uptake of HpHb reached saturation below a concentration of 4 nM ([Figure 4C](#fig4){ref-type="fig"}). In contrast, the uptake of HpSPHb was negligible at a concentration of 4 nM and continued to increase at 62.5 nM ([Figure 4D](#fig4){ref-type="fig"}). Uptake of HpSPHb and HpHb observed in wild-type cells was due to the TbHpHbR, as expected ([@bib47]), as uptake of both ligands into TbHpHbR^−/−^ cells was comparable to that of BSA in the range of ligand concentrations assayed (0--62.5 nM).

Therefore, uptake of dimeric HpHb into trypanosomes occurs efficiently at a significantly lower concentration than that of monomeric HpSPHb. As the monovalent affinities of the receptor for HpHb and HpSPHb are indistinguishable, as measured by surface plasmon resonance, this suggests that more efficient uptake of HpHb is caused by the dimeric ligand simultaneously binding to two receptors. Indeed, measurements of the binding of HpHb to immobilised receptor, using a very high surface density of HpHbR to measure bivalent binding, gave an affinity of 4.5 nM ([@bib16]), which is in the same range as the concentration at which HpHb uptake becomes saturated in live parasites. Therefore, it appears as though TbHpHbR has evolved a kink to increase accessibility of its ligand-binding site and to allow simultaneous binding of two receptors to one HpHb ligand, increasing ligand avidity and uptake efficiency.

Discussion {#s3}
==========

The external surface of an African trypanosome is covered with a tightly packed layer of variant surface glycoprotein that shields epitopes that lie close to the plasma membrane from antibody binding ([@bib41]). Receptors such as those required for the uptake of transferrin and haptoglobin-haemoglobin complexes must operate within the context of this coat, with their structures organised such that ligand binding sites are not masked by the VSG layer.

Here, the first structure of a trypanosome receptor in complex with its ligand is presented: that of the *T. brucei* haptoglobin-haemoglobin receptor bound to haptoglobin-haemoglobin. Remarkably, the ligand-binding site extends more that half the way along the receptor, forming distinct binding surfaces for the β-subunit of haemoglobin and for haptoglobin. The simultaneous binding of both components explains the specificity of the receptor for haptoglobin-haemoglobin complexes over each individual component. However, the extent of the binding surface places it below the top of the VSG layer, apparently increasing the likelihood that it will be masked by VSG.

However, a ∼50° rigid kink occurs as an adaptation in the three helical bundle of the *T. brucei* receptor, and we propose that it has two main functional consequences. Firstly, the direction of the kink is precisely arranged to bend the receptor such that the ligand-binding site becomes more exposed at the membrane surface. The kink will also increase the effective diameter of the receptor in the plane of the membrane. This combination is likely to increase the separation of VSG molecules in the region of the receptor and to increase the accessibility of the binding site for bulky macromolecular ligands such as HpHb and trypanolytic factors. Increased separation of VSG molecules by a trypanosome receptor is not a novel phenomena, with bulky glycan chains attached to the transferrin receptor proposed to have a similar effect ([@bib28]), suggesting that different receptors increase the accessibility of binding sites for bulky ligands by different means.

The precise nature of the integration of TbHpHbR into the VSG layer remains unresolved as the effect of the C-terminal domains of both the receptor and VSG on the vertical disposition of each molecule remains unknown. An attractive model is that the ligand, whether HpHb or TLF1, is bound above the top of the VSG. However, the dimensions of the structures of VSG and the TbHpHbR:HpHb complex suggest that this may not be the case and that the HpHb ligand is held at least partially within the VSG layer ([Figure 5](#fig5){ref-type="fig"}). The TLF1 ligand is ∼4 times the size of HpHb and this must, at least partially, protrude above the top of the VSG layer. 10.7554/eLife.05553.020Figure 5.A comparison of the dimensions of the TbHpHbR:HpHb complex with those of the N-terminal domains of the variant surface glycoproteins (shown in grey).This suggests that HpHb will lie at least partially within the VSG layer when bound to two receptors.**DOI:** [http://dx.doi.org/10.7554/eLife.05553.020](10.7554/eLife.05553.020)

A second consequence of the kink is to allow two receptors to simultaneously bind to one dimeric HpHb complex when their membrane-proximal C-termini are membrane-attached. The affinity of a single receptor for HpHb is modest, at ∼1 μM, with a rapid off-rate. By enabling two receptors to bind simultaneously, the kink will increase the ligand avidity, changing the effective affinity to something in the low nanomolar range, as previously measured for bivalent binding by TbHpHbR ([@bib16]) and to live cells ([@bib8]).

What is the likelihood of two receptors interacting with a single ligand on the cell surface? The receptor copy number is 200--400 and it is concentrated in the flagellar pocket ([@bib47]). The surface area of the flagellar pocket in live cells is 4.3 µm^2^ ([@bib13]). If there are 200 receptor molecules in the membrane of the flagellar pocket then the density is one receptor per 0.022 µm^2^. The diffusion constant for HpHbR is unknown, but the diffusion constant for another GPI-anchored protein, VSG, has been measured by fluorescence recovery after photobleaching to be 0.01 µm^2^/s ([@bib5]); this means that the receptor will contact a receptor molecule approximately every 2 s. The t~1/2~ for release of monovalently bound HpHb is 70--100 s ([@bib16]) ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), so if it is assumed that the receptor has a similar diffusion coefficient to the VSG, then it is very likely that a monovalently bound ligand will become bivalently bound. Indeed our analysis of uptake of dimeric HpHb and monomeric HpSPHb into *T. brucei* confirmed that this increased avidity does occur in vivo, with HpHb uptake saturating at a concentration below 4 nM, while HpSPHb uptake is far from saturation at 62.5 nM.

Whether other trypanosome receptors use a similar avidity-increase mechanism to improve the efficiency of ligand uptake remains to be seen, and whether it is required will depend upon the receptor affinity for monomer and the sera concentration of the nutrient. However, it is clear from the example of TbHpHbR that this mode of ligand binding is potentially applicable to other GPI-anchored cell surface proteins.

While the evolution of the kink allows increased accessibility of the binding site for HpHb, it would also increase accessibility for the large TLF1 complex. One mechanism used by human infective *T. b. gambiense* to avoid TLF1-mediated innate immunity is a point polymorphism in HpHbR that reduces the monovalent affinity for HpHb by 20-fold ([@bib16]) and reduces TLF1 uptake ([@bib21]). It remains to be seen whether TLF1 contains one or multiple HprHb complexes, and whether these are in a suitable arrangement to allow bivalent binding. However, even if bivalent binding does occur in TLF1, the difference in affinity due to the *T. b. gambiense* polymorphism will be amplified under conditions where two receptors bind to a single ligand.

As the kink in the receptor appears to have a number of functional consequences that facilitate ligand uptake, it is surprising that the *T. congolense* receptor lacks such a kink. One reason for this difference might be the lack of a C-terminal domain in *T. congolense* surface proteins ([@bib16]). Perhaps the direct attachment of the ligand-binding domain to a GPI-anchor provides enough flexibility to allow the receptors to adopt an angle that allows simultaneous uptake, or perhaps the VSG coat of *T. congolense* parasites is less densely packed. These questions will need further study.

In conclusion, we present the first structure of a trypanosome receptor in complex with its ligand and reveal a number of adaptations that are tailored to facilitate efficient ligand binding in the context of the VSG coat. These will decrease the packing of VSG molecules in the immediate vicinity of the receptor and increase accessibility of the ligand-binding site. They also allow two receptors to bind to a single ligand, thereby increasing avidity and dramatically decreasing the ligand concentration at which efficient uptake occurs. While different adaptations might facilitate each of these goals in different receptors, we would expect them to be general principles, frequently used by the parasite to aid nutrient uptake and survival.

Materials and methods {#s4}
=====================

*T. brucei* HpHbR cloning, expression and purification {#s4-1}
------------------------------------------------------

Full-length *T. b. brucei* HpHbR, without the N-terminal signal sequence and C-terminal GPI-anchor addition sequence, had been previously cloned for expression in a modified pET-15b to generate a polypeptide with an N-terminal hexahistidine tag and a cleavage site for TEV protease ([@bib16]). To produce a truncated construct for expression of the N-terminal ligand-binding domain, a stop codon was inserted after residue R299 using a polymerase chain reaction based mutagenesis protocol, using oligonucleotide `GAGATGAAGCGCTAGGGGAACCCGATC` and its reverse-complement. Mutagenesis was carried out as described for the Quikchange mutagenesis method (Stratagene, La Jolla, CA) and the plasmid was sequence verified.

The protein was expressed in *E. coli* Origami B, induced with 1 mM IPTG and incubated overnight at 18°C. The protein was purified by Ni^2+^-NTA affinity chromatography and cleaved overnight with his-tagged TEV protease at 4°C in PBS with 3 mM oxidized glutathione, 0.3 mM reduced glutathione, followed by reverse Ni^2+^-NTA affinity chromatography. The protein was concentrated by Amicon Ultra centrifugal filter device (10,000 MWCO) (EMD Millipore, Billerica, MA) and gel filtered using a Superdex 75 16/60 column (Life Technologies, Carlsbad, CA) into 20 mM HEPES pH 7.5, 150 mM NaCl.

HpSP and HprSP cloning, expression and purification {#s4-2}
---------------------------------------------------

Synthetic genes encoding the SP domains of human Hp (148--406) and Hpr (90--348) were cloned into a modified pAcGP67A vector to generate a polypeptide with an N-terminal hexahistidine tag and a cleavage site for TEV protease. These were transfected into Sf9 insect cells using the BaculoGold Baculovirus DNA transfection protocol (BD Biosciences, Franklin Lakes, NJ). Following selection of virus using plaque assays, the third amplification of recombinant virus was used to infect Sf9 insect cells. After 3 days, the cells were centrifuged for 15 min at 6000×*g*. After filtering, the supernatant was buffer exchanged into 20 mM Tris pH 8, 300 mM NaCl using a tangential flow apparatus (Pall Corporation, Port Washington, NY), followed by Ni^2+^-NTA affinity chromatography. The protein was concentrated using an Amicon Ultra centrifugal filter device (10,000 MWCO) (EMD Millipore). When used for crystallisation, HpSP was deglycosylated by incubation with endoglycosidase Hf (Sigma-Aldrich, St Louis, MO) and endoglycosidase F3 at enzyme:protein ratios of 1:25 in 1 mM CaCl~2~, 1 mM MgCl~2~, 100 mM HEPES pH 7.5 at 37°C for 3 hr.

Purification of Hb and formation of the HpHb complex {#s4-3}
----------------------------------------------------

Hb was isolated from human blood by sonication, followed by anion exchange chromatography using a Mono Q column (Life Technologies). HpHb was made by mixing full-length Hp 1-1 (Sigma-Aldrich) with purified Hb and isolating the complex by gel filtration using a Superdex 200 16/60 column (Life Technologies) in 20 mM HEPES pH 7.5, 150 mM NaCl.

HpSPHb and HprSPHb complex formation {#s4-4}
------------------------------------

HpSP or HprSP at a threefold molar excess was mixed with Hb and diluted fivefold into 20 mM Tris pH 8, 500 mM NaCl, 15 mM imidazole. The complex was purified by Ni^2+^-NTA affinity chromatography, washed using the dilution buffer, and eluted into PBS containing 200 mM imidazole. The complexes were then concentrated using an Amicon Ultra centrifugal filter device (10,000 MWCO) (EMD Millipore), and purified by gel filtration using a Superdex 200 16/60 column (Life Technologies) in 20 mM HEPES pH 7.5, 150 mM NaCl.

Crystallisation, data collection and structure determination of the HpSPHb complex {#s4-5}
----------------------------------------------------------------------------------

HpSPHb was concentrated to 15 mg ml^−1^ for crystallization. Crystals were obtained after 8 hr in sitting drops with a well solution containing 0.2 M NaCl, 0.1 M sodium cacodylate pH 6.5 and 2 M ammonium sulphate. These were cryoprotected by transfer into well solution with the addition of 30% vol/vol glycerol before cryo-cooling using liquid nitrogen. Data were collected on beamline I04-1 at the Diamond light source and were integrated and scaled using iMosflm ([@bib2]) and scala ([@bib11]) from the CCP4 suite ([@bib49]), giving a final resolution of 2.05 Å. The structure was determined by molecular replacement using Phaser ([@bib27]) with the equivalent region of the porcine HpHb (pdb: 4F4O) as a search model. The structure was rebuilt and refined using Coot ([@bib9]) and REFMAC ([@bib29]).

Crystallisation, data collection and structure determination of the TbHpHbR:HpSPHb complex {#s4-6}
------------------------------------------------------------------------------------------

TbHpHbR was mixed with HpSPHb and purified by gel filtration using a Superdex 200 16/600 column (Life Technologies) into a buffer containing 150 mM NaCl and 20 mM HEPES pH 7.5. It was concentrated to a final concentration of 15 mg ml^−1^ and crystallised at 18 °C using sitting drops with a well solution containing 12.5% vol/vol MPD, 0.03 M NaBr, 0.03 M NaI, 0.03 M NaF, 0.1 M MES/imidazole pH 6.5, 12.5% wt/vol PEG 1000, 12.5% wt/vol PEG 3350 from the Morpheus screen (Molecular Dimensions, UK). Crystals formed after 10 days. Seed beads (Hampton Research, Aliso Viejo, CA) were used to create seeds from these crystals. These were used to seed a plate containing 100 nl of protein, 50 nl of the Morpheus well solution, and 50 nl of the Silver Bullet additive screen (Hampton Research). Crystals grew after 8 days in the well containing additives 0.2% wt/vol 2,2′-thiodiglcolic acid, 0.2% wt/vol apidic acid, 0.2% wt/vol benzoic acid, 0.2% wt/vol oxalic acid anhydrous, 0.2% wt/vol terephthalic acid. These were cryo-cooled in liquid nitrogen in the Morpheus well solution.

Data were collected on beamline I03 at the Diamond light source. Data reduction was performed using XDS ([@bib20]) and the structure was solved by molecular replacement with the HpSPHb structure as a search model using Phaser ([@bib27]). Automatic model building in Buccaneer ([@bib7]) was used to identify the positions of the receptor helices, leading to a cycle of model building and refinement in Coot ([@bib9]) and Buster ([@bib4]). The coordinates from the higher resolution structures of both and TbHpHbR, also determined during this study, were used to provide restraints during refinement, leading to improved stereochemistry of the resultant model.

Crystallisation, data collection and structure determination of TbHpHbR {#s4-7}
-----------------------------------------------------------------------

The receptor was concentrated to 12.5 mg ml^−1^ for crystallization. Crystals were obtained at 18 °C after 7 days using sitting drops with a well solution of 0.15 M KBr, 30% wt/vol PEG 2000 MME from the JCSG+ screen (Molecular Dimensions). These were partially dehydrated and cryoprotected by transfer into the well condition with addition of 30% vol/vol glycerol before cryo-cooling in liquid nitrogen.

Data were collected on beamline I03 at the Diamond light source. Data reduction was performed using iMosflm ([@bib2]) and scala ([@bib11]) from the CCP4 data processing suite ([@bib49]). Molecular replacement was performed using Phaser ([@bib27]), with the structure of TbHpHbR taken from the TbHpHbR:HpSPHb complex as a search model. A cycle of refinement and model building was carried out using REFMAC ([@bib29]) and Coot ([@bib9]).

Small-angle X-ray scattering (SAXS) data collection and processing {#s4-8}
------------------------------------------------------------------

SAXS data for TbHpHbR alone and in complex with HpSPHb, and for the complex of TcHpHbR with HpSPHb, were collected at the PetraIII P12 beamline at Deutsches Elektronen-Synchrotron using a wavelength of 1.24 Å. SAXS data for the complex of the receptor with dimeric HpHb were collected at beamline BM29 at the European Synchrotron Radiation Facility using a wavelength of 0.9 Å. SAXS data for HpHb alone was collected at beamline B21 at the Diamond Light Source with a wavelength of 1.0 Å. In all cases, scattering was detected using a Pilatus image reader at 20°C.

The receptors alone and in complex with HpSPHb, as well as HpHb alone, were prepared at concentrations of 2.0, 1.0, 0.5, 0.25 and 0.125 mg ml^−1^ in 20 mM HEPES pH 7.5, 150 mM NaCl. Twenty consecutive frames of 10 s each were recorded for each protein sample with a buffer sample measured between each, except HpHb, for which 180 consecutive 1 s frames were taken. Any images where the data had been affected by protein radiation damage were excluded from further processing.

The complex with dimeric HpHb was prepared and analysed by size-exclusion column (SEC)-SAXS, using a Superdex 200 10/300 column (Life Technologies) in 20 mM HEPES pH 7.5, 150 mM NaCl with a running speed of 0.4 ml min^−1^. One frame was collected every 2 s. Frames corresponding to the peak seen on the UV trace were selected and a curve representing the scattering due to buffer was produced by averaging ten frames from the beginning of the run.

For each data set, PRIMUS ([@bib22]; [@bib35]) was used to normalize data to the intensity of the incident beam, for averaging of equivalent images and to subtract scattering due to buffer. Where Guinier plots revealed aggregation due to high concentration, data were removed ([@bib14]). Composite curves were generated by scaling and merging the data sets.

AutoRg calculated the distance distribution function (P(r)) using an indirect Fourier transform, allowing estimation of the radius of gyration (R~g~), the maximum particle dimension (D~max~) and the Porod volume ([@bib36]) by GNOM ([@bib35]). Initial models of the shape were generated using DAMMIF ([@bib12]) and averaged using the DAMAVER programme suite ([@bib23]). DAMMIN then produced a final model by minimising differences between experimental data and scattering of the model. The envelope model was produced using Situs ([@bib3]), and feature-based docking of the crystal structures was completed using Sculptor ([@bib3]).

Surface plasmon resonance {#s4-9}
-------------------------

Measurements were performed on a Biacore T200 (Life Technologies) instrument with a constant flow rate of 30 μg ml^−1^. A CM5 chip was prepared by flowing over a 1:1 mixture of ethyl-dimethylaminopropyl-carbodiimide and N-hydroxysuccinimide. TbHpHbR was diluted into 10 mM sodium acetate pH 5 to a final concentration of 0.1 μM.

Ligands were diluted into HBS (20 mM HEPES pH 7.5, 150 mM NaCl, 0.005% vol/vol Tween 20). Both channels were equilibrated with HBS before injection of binding partner, and the level of specific binding obtained from a subtraction of the response from channel 2 from that of channel 1. Values for K~D~ were obtained by equilibrium binding analysis using the BIAevaluation software.

Size exclusion chromatography-multiangle laser light scattering {#s4-10}
---------------------------------------------------------------

Purified samples were loaded onto a Superose 6 10/300 column (GE Healthcare), then analysed using laser light scattering detected at 662 nm wavelength at 8 scattering angles between 20.6° and 149.1° using a Heleos 8 instrument (Wyatt Technology, Germany). ASTRA 6.1 (Wyatt Technology) was used to calculate molecular weights using the Zimm equation. The samples were loaded at concentrations of 10 μM for HpHb and 40 μM for TbHpHbR.

Trypanosome cell culture and construction of *T. brucei* HpHbR^−/−^ cell line {#s4-11}
-----------------------------------------------------------------------------

*T. brucei* blood stream form cells were grown in HMI-9 at 37 °C with 5% CO~2~ ([@bib17]). The linear DNAs used to replace HpHbR genes by homologous recombination were produced by PCR. First, one allele was replaced in procyclic form Lister 427 cells using a PCR product that contained 80 bp from upstream of the HpHbR gene, followed by the blasticin resistance cassette, followed by 80 bp from downstream of the HpHbR gene. The same approach was used with a G418 resistance cassette. Genomic DNA was prepared from blasticin or G418 resistant cell lines and used as a template for a PCR using oligonucleotides 500 bp upstream and downstream of the HpHbR gene. These second PCR products were used to serially transfect Lister 427 bloodstream form cells expressing VSG118.

Uptake assays for monitoring uptake of fluorescently labelled ligands into live cells {#s4-12}
-------------------------------------------------------------------------------------

When used for uptake experiments, Hp, HpSP and BSA were labelled with Alexa Fluor 488 using the protein labelling kit (Life Technologies). The manufacturer\'s protocol was adapted, extending the reaction time to overnight at 4 °C to increase labelling efficiency. Hp and HpSP were then subsequently mixed with Hb to form complex as above. For each assay, 5 × 10^6^ wild type Lister 427 or *HpHbR* ^*−/−*^ cells were resuspended in 100 µl of serum free HMI-9 with 1% BSA and incubated with 2 µM protease inhibitor FMK-024 for 10 min at 37 °C. Cells were then incubated with 1--62.5 nM fluorescently labelled protein for 2 hr at 37 °C before being washed twice in serum free HMI-9 with 1% BSA. Cells were fixed in 4% paraformaldehyde for 10 min at room temperature and resupended in PBS. Uptake was assayed by flow cytometry using a FACScan (BD Biosciences) and quantified on FlowJo software. Mode increase in fluorescence was measured relative to a no ligand negative control, and all assays were carried out in triplicate.
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Thank you for sending your work entitled "Structural basis for ligand and innate immunity factor uptake by the trypanosome haptoglobin-haemoglobin receptor" for consideration at *eLife*. Your article has been favorably evaluated by John Kuriyan (Senior editor) and 3 reviewers, one of whom is a member of our Board of Reviewing Editors.

The following individuals responsible for the peer review of your submission have agreed to reveal their identity: Volker Dötsch (Reviewing editor) and Michael Ferguson (peer reviewer).

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

This manuscript describes the structural investigation of the haptoglobin-haemoglobin receptor (HpHbR) of *Trypanosoma brucei* in complex with human haptoglobin-haemoglobin(HpHb) by x-ray crystallography as well as SAXS measurements. This is an important interaction in trypanosome molecular biology, as it allows the parasite to acquire haem, and it is relevant to the innate immune response humans have to many species of trypanosome parasites. While the structures of the individual components were largely known previously, the details of their complex were hitherto unknown and are revealed for the first time here. The biological experiments, demonstrating the different efficiencies of receptor-mediated uptake of monomeric and dimeric HpHb ligands are an important component of the paper that nicely supports the structure-based hypotheses on increased ligand avidity made possible by a \'two receptors bind one ligand dimer\' model.

Overall, the reviewers consider this a very nice paper showing important results. The reviewers have not found any major concerns but have pointed out some minor issues and questions that are summarized below.

Reviewer \#2

1\) I would suggest that the authors consider presenting a final figure of how they think a receptor pair/ligand dimer would \'sit\' in a sea of VSG molecules (top and side view). This would be helpful for the reader, and I am sure would be popular as a discussion and teaching aid.

2\) While I like the receptor pair/ligand dimer model (particularly since it is supported by uptake data) it leaves one quandary not discussed in the paper: how do two HpHbR molecules find each other to bind the ligand dimer with high-avidity? The receptors are GPI anchored (which helps) and so is the VSG coat so they presumably can wander the surface but what is the probability of a 3-way collision (of 2 independent receptors and a ligand dimer) on a 2-dimensional surface when the density of the receptors is low? Is the model of transient single receptor-ligand dimer interactions that are occasionally \'locked down\' when another receptor arrives by chance? Some discussion I think is called for (but not additional experiments).

Reviewer \#3

I am not an expert on small angle X-ray scattering, but it seems to me that the envelope is a tight fit for the model in [Figure 2A](#fig2){ref-type="fig"} and a generous fit in [Figure 2B](#fig2){ref-type="fig"}. The authors might comment on this. While these data are largely confirmatory, the SAXS data in [Figure 4](#fig4){ref-type="fig"} are predictive, and there needs to be confidence in the interpretations.

Many of the structure Figures (and especially [Figure 2](#fig2){ref-type="fig"}) would benefit from stereo views.

The paragraph "TLF1enters trypanosomes via receptor mediated endocytosis...", in the Introduction section, is confusing and does not clearly explain what TLF1 and TLF2 are. The nomenclature in this paper (field) is quite complex. I wonder if some sort of introductory figure could help.

The 50 degree kink is interesting and interpreted in terms of sequence variations. It would be useful to add some comment about how main chain hydrogen bonding is affected.

In the Results section ("The structure of TbHpHbR in complex with haptoglobin-haemoglobin"), what does the 1250 Å^2^ refer to? Is it the sum of the areas buried on the partner proteins or is it the interface area?

In the Hb field, the helices have always been denoted by letters, A--H in the case of the β-chain, rather than numbers.

In [Table 2](#tbl2){ref-type="table"}, the refinement statistics for TbbHpHbR:HpSPHb look outstanding for a structure at modest resolution especially compared to the Tbb HpHbR structure. The authors should comment briefly on this.

10.7554/eLife.05553.022

Author response

Reviewer \#2

*1) I would suggest that the authors consider presenting a final figure of how they think a receptor pair/ligand dimer would \'sit\' in a sea of VSG molecules (top and side view). This would be helpful for the reader, and I am sure would be popular as a discussion and teaching aid*.

We have been hesitant to produce a model showing the structure of the TbHpHbR: HpHb complex in the context of the VSG layer mainly because of our lack of knowledge of the relative sizes of the C-terminal domains of TbHpHbR and VSG. When TbHpHbR adopts a tilted conformation on binding to HpHb it is approximately the same height as a VSG molecule, making it likely that the HpHb will lie, at least partially, within the VSG layer. We have now included a figure to show this similarity, but do not feel comfortable to go further in proposing a detailed model.

*2) While I like the receptor pair/ligand dimer model (particularly since it is supported by uptake data) it leaves one quandary not discussed in the paper: how do two HpHbR molecules find each other to bind the ligand dimer with high-avidity? The receptors are GPI anchored (which helps) and so is the VSG coat so they presumably can wander the surface but what is the probability of a 3-way collision (of 2 independent receptors and a ligand dimer) on a 2-dimensional surface when the density of the receptors is low? Is the model of transient single receptor-ligand dimer interactions that are occasionally \'locked down\' when another receptor arrives by chance? Some discussion I think is called for (but not additional experiments)*.

The point made about the likelihood of two receptors colliding with a single HpHb is an interesting one. Assuming that the receptors are predominantly localised at the flagellar pocket, and using the known receptor copy number and VSG diffusion rates, we have calculated that each receptor should contact another receptor approximately once each second. As the t~1/2~ for the dissociation of HpHb from a single receptor is in the region of 70-100 s, there is a strong likelihood that an HpHb attached to a single receptor will interact with a second receptor before it dissociates, leading to higher avidity bivalent binding. We have added a paragraph to the Discussion section to make this point.

Reviewer \#3

*I am not an expert on small angle X-ray scattering, but it seems to me that the envelope is a tight fit for the model in* [*Figure 2A*](#fig2){ref-type="fig"} *and a generous fit in* [*Figure 2B*](#fig2){ref-type="fig"}*. The authors might comment on this. While these data are largely confirmatory, the SAXS data in* [*Figure 4*](#fig4){ref-type="fig"} *are predictive, and there needs to be confidence in the interpretations*.

We agree with the reviewer that it is essential to be confident about the interpretation of the data supporting the formation of a complex containing two receptors bound to a single HpHb in solution. We have made two changes to the manuscript to present data that strengthens this conclusion. Firstly, we now include SAXS data for HpHb alone, allowing comparison with that for the HpHbR:receptor complex. The envelopes derived from these data, together with the accompanying molecular weights, support the binding of two receptors to each HpHb. In addition, we have included SEC-MALLS data, which also shows the formation of a complex containing two receptors bound to a single HpHb. These biophysical data support the conclusions derived from crystallography and explain the in vivo effects observed in HpHb uptake experiments.

*Many of the structure Figures (and especially* [*Figure 2*](#fig2){ref-type="fig"}*) would benefit from stereo views*.

We have added a new figure supplement for [Figure 2](#fig2){ref-type="fig"} to show a stereoview of the TbHpHbR:HpSPHb complex.

*The paragraph "TLF1enters trypanosomes via receptor mediated endocytosis...", in the Introduction section, is confusing and does not clearly explain what TLF1 and TLF2 are. The nomenclature in this paper (field) is quite complex. I wonder if some sort of introductory figure could help*.

We have clarified the paragraph on the trypanolytic factors in the Introduction, simplifying our description of these (imperfectly characterised) factors and focusing our discussion onto the key ApoLI and Hpr components. We have also rearranged the subsequent two paragraphs. We believe that this will improve their clarity to a reader from outside the field and give a balanced view of what we know of the role of the HpHbR in mediating innate immunity.

*The 50 degree kink is interesting and interpreted in terms of sequence variations. It would be useful to add some comment about how main chain hydrogen bonding is affected*.

We have added a sentence to the description of the kink in TbHpHbR in which we clarify the effect on main chain hydrogen bonding, and we describe which residues in each of the three helices have their hydrogen bonding disrupted.

*In the Results section ("The structure of TbHpHbR in complex with haptoglobin-haemoglobin"), what does the 1250 Å*^*2*^ *refer to? Is it the sum of the areas buried on the partner proteins or is it the interface area*?

The area of 1250 Å^2^ is the interface area, i.e. the area on the receptor that is covered by HpHb, and not the sum of the buried surface areas on both proteins. We have clarified this in the text.

*In the Hb field, the helices have always been denoted by letters, A--H in the case of the β-chain, rather than numbers*.

We have corrected the labelling of the haemoglobin β-subunit helices, with helices C and F indicated as those that contact the receptor.

*In* [*Table 2*](#tbl2){ref-type="table"}*, the refinement statistics for TbbHpHbR:HpSPHb look outstanding for a structure at modest resolution especially compared to the Tbb HpHbR structure. The authors should comment briefly on this*.

We agree with the reviewer that the refinement statistics for the TbHbHpR:HpSPHb structure are very good. This is, in part, due to the use of additional restraints from the higher resolution structures of the receptor and the HpSPHb complex during refinement. As neither structure showed any conformational change upon complex formation, these additional restraints were used to improve the stereochemistry of the refined model. We were careful, by comparison of the final maps with those obtained without use of these restraints, to show that their use did not lead to major changes in the model. We have increased our explanation of our refinement procedure in the Materials and methods to clarify this.

In addition, we have deposited the pdb codes and diffraction data to the protein data bank with codes 4X0I, 4X0J and 4X0L.
